Bicycle Therapeutics (BCYC) Retained Earnings (2018 - 2026)

Bicycle Therapeutics has reported Retained Earnings for 9 years, with the latest figure at -$960.6 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 65647.84% year-over-year to -$960.6 million; the trailing twelve-month figure through Mar 2026 stood at -$960.6 million (down 65647.84% YoY), and the FY2025 full-year result was -$3.5 million, up 99.49% from the prior year.
• Retained Earnings for Q1 2026 stood at -$960.6 million, down from -$3.5 million in the prior quarter.
• The five-year high for Retained Earnings was -$778000.0 in Q1 2024, with the low at -$960.6 million in Q1 2026.
• Historically, Retained Earnings has averaged -$387.8 million across 5 years, with a median of -$370.2 million in 2023.
• Annual changes were most pronounced in 2024 — Retained Earnings surged 99.79% — and 2026, when it slumped 65647.84%.
• Bicycle Therapeutics' Retained Earnings stood at -$331.1 million in 2022, then slumped by 54.57% to -$511.8 million in 2023, then tumbled by 33.03% to -$680.8 million in 2024, then surged by 99.49% to -$3.5 million in 2025, then plunged by 27305.88% to -$960.6 million in 2026.
• The last three Retained Earnings figures came in at -$960.6 million (Q1 2026), -$3.5 million (Q4 2025), and -$879.6 million (Q3 2025), per Business Quant data.